David I. Watson

23.4k total citations
428 papers, 13.0k citations indexed

About

David I. Watson is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David I. Watson has authored 428 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 336 papers in Surgery, 174 papers in Gastroenterology and 129 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David I. Watson's work include Gastroesophageal reflux and treatments (165 papers), Esophageal and GI Pathology (162 papers) and Esophageal Cancer Research and Treatment (103 papers). David I. Watson is often cited by papers focused on Gastroesophageal reflux and treatments (165 papers), Esophageal and GI Pathology (162 papers) and Esophageal Cancer Research and Treatment (103 papers). David I. Watson collaborates with scholars based in Australia, United Kingdom and United States. David I. Watson's co-authors include Peter G. Devitt, Glyn G. Jamieson, G. G. Jamieson, Philip A. Game, Charles Hinds, R J Baigrie, George Mathew, Susan J. Neuhaus, Rupert M. Pearse and R Britten-Jones and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David I. Watson

411 papers receiving 12.5k citations

Peers

Countries citing papers authored by David I. Watson

Since Specialization

Citations

This map shows the geographic impact of David I. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Watson more than expected).

Fields of papers citing papers by David I. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David I. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Watson. The network helps show where David I. Watson may publish in the future.

Co-authorship network of co-authors of David I. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of David I. Watson. A scholar is included among the top collaborators of David I. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David I. Watson. David I. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lessons from a population‐based bladder cancer registry: exploring why survival is not improving 2024 ·British Journal of Urology ·(unknown), (unknown), Joseph Ischia, Damien Bolton, Katina D’Onise, Xingqiong Meng, David I. Watson, Michael O’Callaghan	2
2	A Markov cohort model for Endoscopic surveillance and management of Barrett’s esophagus 2024 ·SHILAP Revista de lepidopterología ·(unknown), Norma B. Bulamu, Roger Yazbeck, Jonathan Karnon, David I. Watson	1
3	Mucosal impedance as a diagnostic tool for gastroesophageal reflux disease: an update for clinicians 2024 ·Diseases of the Esophagus ·(unknown), Jennifer C. Myers, David I. Watson, Tim Bright, Taher Omari, Sarah K. Thompson	2
4	Quantifying Perioperative Risks for Antireflux and Hiatus Hernia Surgery 2024 ·Annals of Surgery ·David S. Liu, Darren Wong, Su Kah Goh, (unknown), Sean Stevens, Ahmad Aly, Tim Bright, Laurence Weinberg, David I. Watson, (unknown)	2
5	Sutured Versus Mesh-Augmented Hiatus Hernia Repair: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 2021 ·Annals of Surgery ·(unknown), Tim Bright, (unknown), (unknown), David I. Watson	18
6	Cross validated serum small extracellular vesicle microRNAs for the detection of oropharyngeal squamous cell carcinoma 2020 ·Journal of Translational Medicine ·George C. Mayne, Charmaine M. Woods, (unknown), (unknown), (unknown), (unknown), Andrew Foreman, Samuel Boase, A. Simon Carney, Elizabeth Sigston, David I. Watson, Eng H. Ooi, Damian J. Hussey	14
7	Clinical pathways and outcomes of patients with Barrett’s esophagus in tertiary care settings: a prospective longitudinal cohort study in Australia, 2008–2016 2020 ·Diseases of the Esophagus ·Renhua Na, Kyoko Miura, Suzanne O’Brien, Guy D. Eslick, Bradley J. Kendall, Luke F. Hourigan, Michael J. Bourke, Michael R. Cox, (unknown), Angelique Levert‐Mignon, Andrew P. Barbour, Nicholas J. Clemons, Cuong Duong, Reginald V. Lord, Wayne A. Phillips, David I. Watson, David C. Whiteman	2
8	The Use of Selected Ion Flow Tube-Mass Spectrometry Technology to Identify Breath Volatile Organic Compounds for the Detection of Head and Neck Squamous Cell Carcinoma: A Pilot Study 2019 ·Medicina ·(unknown), Eng H. Ooi, David I. Watson, (unknown), (unknown), Roger Yazbeck	24
9	Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol 2019 ·BMJ Open ·Sina Vatandoust, Tim Bright, Amitesh Roy, David I. Watson, Susan Gan, (unknown), (unknown), Christos S. Karapetis	6
10	Assessing the efficacy and safety of laparoscopic antireflux procedures for the management of gastroesophageal reflux disease: a systematic review with network meta-analysis 2019 ·Surgical Endoscopy ·Alexandros Andreou, David I. Watson, Dimitris Mavridis, Nader Francis, Stavros A. Antoniou	26
11	Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus 2018 ·Molecular & Cellular Proteomics ·Alok K. Shah, Günter Härtel, Ian Brown, Clay Winterford, Renhua Na, Kim‐Anh Lê Cao, Bradley A. Spicer, Michelle A. Dunstone, Wayne A. Phillips, Reginald V. Lord, Andrew P. Barbour, David I. Watson, Virendra Joshi, David C. Whiteman, Michelle M. Hill	24
12	Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing 2017 ·Molecular Cancer Research ·Jesper L.V. Mååg, Oliver M. Fisher, Angelique Levert‐Mignon, Dominik C. Kaczorowski, Mélissa Thomas, Damian J. Hussey, David I. Watson, Antony Wettstein, Yuri V. Bobryshev, (unknown), Marcel E. Dinger, Reginald V. Lord	32
13	Perfect-results after laparoscopic surgery for gastroesophageal reflux - are they achievable? 2013 ·David I. Watson	2
14	miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus. 2011 ·Data Archiving and Networked Services (DANS) ·(unknown), David I. Watson, (unknown), George C. Mayne, Michael Michael, Bas P. L. Wijnhoven, Damian J. Hussey	44
15	Genome-Wide Copy Number Analysis in Esophageal Adenocarcinoma Using High-Density Single-Nucleotide Polymorphism Arrays 2008 ·Cancer Research ·Derek J. Nancarrow, Herlina Y. Handoko, B. Mark Smithers, D. C. Gotley, Paul A. Drew, David I. Watson, Andrew D. Clouston, Nicholas K. Hayward, David C. Whiteman, (unknown)	65
16	Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) in patients with septic shock: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)* 2004 ·Critical Care Medicine ·David I. Watson, Robert F. Grover, Antonio Anzueto, José A. Lorente, Mark Smithies, Rinaldo Bellomo, Kalpalatha K. Guntupalli, Steven H. Grossman, Jill Donaldson, (unknown)	94
17	Administration of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)* 2004 ·Critical Care Medicine ·Jan Bakker, Robert F. Grover, Angela McLuckie, Laurent Holzapfel, Jan Andersson, Robert F. Lodato, David I. Watson, Steven H. Grossman, Jill Donaldson, Jukka Takala	140
18	Randomised controlled trial of ablation of Barrett's oesophagus with argon plasma coagulation in postfundoplication patients: 1-year data 2002 ·Journal of Gastroenterology and Hepatology ·William Tam, Roger Ackroyd, Mark Schoeman, P. Devitt, David I. Watson	1
19	An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shock 1999 ·Critical Care Medicine ·Robert F. Grover, David Zaccardelli, Gene Colice, Kalpalatha K. Guntupalli, David I. Watson, Jean‐Louis Vincent	134
20	Outcome of laparoscopic Nissen fundoplication in patients with disordered preoperative peristalsis. 1997 ·Gut ·R J Baigrie, David I. Watson, Jennifer C. Myers, G. G. Jamieson	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact